29 September 2024 in Astana Medical Journal
Navigating the labyrinth of Autism diagnosis in Kazakhstan can be an arduous journey for families. The scarcity of specialized professionals, coupled with limited awareness and resources, poses significant hurdles for early identification and intervention. This study aimed to offer a comprehensive examination of caregivers' experiences in navigating the process of diagnosing autism in their children within the context of Kazakhstan.Objective: The overarching aim of this study is to illuminate caregivers' experiences in navigating the diagnostic journey for Autism Spectrum Disorder in Kazakhstan, shedding light on factors influencing parental decision-making and elucidating barriers faced by families seeking diagnostic support for their children.Methods. This study involved a mixed interview of caregivers of children diagnosed with childhood autism, atypical autism, about difficulties in the process from initial concern about the child's development to formal diagnosis.Results. On average, autism concerns emerged at 1.91 years, with specialist contact at 2.19 years. Median diagnosis age was 4.51 years, taking 2.45 years from concern. Comorbidities included Attention deficit hyperactivity disorder (16.98%), psycho-speech delay (15.09%), and mental retardation (9.43%). Satisfaction with diagnosis was low (9.43%), yet 41.5% were content. Caregivers struggled with timely diagnosis, facing awareness and support deficits from specialists and society, along with logistical and psychological challenges.Conclusion.The study sheds light on the challenges faced by caregivers in Kazakhstan during the diagnosis of autism in their children. It highlights the delayed age of diagnosis, the prevalence of comorbidities, and the dissatisfaction with diagnostic assistance, underscoring the urgent need for improved access to timely and effective diagnostic services, as well as enhanced support for caregivers navigating the complexities of autism diagnosis.Keywords: autism spectrum disorder, parents’ experience, Kazakhstan.
2 April 2026 in Orthopedic Reviews
Background: Degenerative lumbar spinal stenosis is a leading cause of disability, and lumbar interbody fusion (LIF) is a common surgical option. However, pseudarthrosis and suboptimal fusion remain important limitations. Porous titanium cages with biologically active hydrogels may enhance osteointegration compared with PEEK implants. Methods: This single-centre prospective randomized trial included 50 patients with lumbar stenosis undergoing single-level TLIF. Patients were allocated 1:1 to Group I (trabecular Ti-6Al-4V cage with autologous bone and stromal-vascular fraction–based heparin-conjugated fibrin hydrogel) or Group II (PEEK cage with autologous bone only). Follow-up was 12 months. Primary endpoints were CT-based fusion at 12 months (Tan classification) and bone density within the cage region (Hounsfield units, HU). Secondary outcomes included pain (VAS), disability (ODI), implant subsidence/migration, operative parameters, and complications. Results: Baseline demographic and clinical characteristics and intraoperative blood loss were comparable between groups. Mean HU values were significantly higher in Group I at 3–4, 6 and 12 months (428.0±68.6 vs 388.8±46.6, p=0.0228; 527.5±81.8 vs 466.4±52.7, p=0.0031; 594.8±78.7 vs 521.0±75.0, p=0.0014). Complete fusion (Tan grade 1) at 12 months was achieved in 68% of Group I versus 32% of Group II patients (p=0.0227). Group I also showed greater VAS and ODI improvement at all postoperative time points. No intraoperative complications or hydrogel-related adverse events were observed. Conclusions: A trabecular titanium cage combined with autologous bone and SVF-based hydrogel appears safe and more effective than a PEEK cage with autograft, providing superior radiological fusion and faster recovery at 12 months